Alexion Pharma (ALXN) Asfotase Alfa Granted Orphan Drug Designation in Japan
Tweet Send to a Friend
Alexion Pharma (Nasdaq: ALXN) announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE